[Research Progress in Immune Checkpoint Inhibitors Combination Therapy Applied to  Non-small Cell Lung Cancer after EGFR Mutation-targeted Therapy Resistance]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.